| Effects of hyperbaric oxygen therapy on the treatment of severe cases of periodontitis. | |
| | |
MedLine Citation:
|
PMID: 20462143 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To evaluate the effect of hyperbaric oxygen therapy (HBO2) as an adjunct to scaling and root planing (SRP) in the treatment of severe cases of chronic periodontitis. MATERIALS AND METHODS: In 20 patients diagnosed with severe generalized chronic periodontitis (pockets>7mm) with bleeding on probing, SRP was rendered in all pockets. Additionally, five consecutive hyperbaric sessions were administered in 10 patients after random allocation (SRP + HBO2). Clinical parameters were assessed at baseline up to six months: plaque index, bleeding on probing, probing depth, clinical attachment level and benzoyl-DL-arginine-naphthylamide (BANA) test. RESULTS: SRP + HBO2 resulted in greater probing reduction and attachment gain than SRP alone three months after treatment (p<0.001). The BANA test was negative after one week only for sites in the SRP + HBO2 group (p<0.05). However, SRP + HBO2 failed to show a significant difference from SRP group after 3 months, where all BANA sites became negative (p>0.05). CONCLUSION: Our data suggest that hyperbaric oxygen therapy had a short-term beneficial effect on pocket reduction and bacterial elimination, and may be considered a potential adjunct therapeutic option to improve the clinical outcomes of scaling in severe cases of chronic periodontitis. |
| | |
Authors:
|
Getulio R Nogueira-Filho; Bruno T Rosa; Joao R David-Neto |
Related Documents
:
|
20684513 - Orthogonal photocleavage of a monochromophoric linker. 17658183 - Aggressive periodontitis associated with papillon-lefèvre syndrome: report of a 14-yea... 15307393 - Monovision laser in situ keratomileusis for pre-presbyopic and presbyopic patients. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc Volume: 37 ISSN: 1066-2936 ISO Abbreviation: Undersea Hyperb Med Publication Date: 2010 Mar-Apr |
Date Detail:
|
Created Date: 2010-05-13 Completed Date: 2010-06-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9312954 Medline TA: Undersea Hyperb Med Country: United States |
Other Details:
|
Languages: eng Pagination: 107-14 Citation Subset: IM; S |
Affiliation:
|
Department of Dental Diagnostic and Surgical Sciences, University of Manitoba, Canada. nogueira@cc.umanitoba.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Benzoylarginine-2-Naphthylamide / diagnostic use Brazil Chronic Periodontitis / diagnosis, microbiology, therapy* Dental Scaling / methods Female Humans Hyperbaric Oxygenation / methods* Male Pilot Projects Root Planing / methods Single-Blind Method |
| Chemical | |
Reg. No./Substance:
|
305-09-9/Benzoylarginine-2-Naphthylamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hyperbaric oxygen therapy and age-related macular degeneration.
Next Document: Treating necrotizing fasciitis with or without hyperbaric oxygen therapy.